​

Basel Medical Group Ltd Ordinary Shares (BMGL) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Basel Medical Group Ltd Ordinary Shares Revenue Highlights

Latest Revenue (Y)

$10.05M

Latest Revenue (Q)

$6.05M

Basel Medical Group Ltd Ordinary Shares Revenue by Period

Basel Medical Group Ltd Ordinary Shares Revenue by Year

DateRevenueChange
2024-06-30$10.05M3.60%
2023-06-30$9.70M-8.98%
2022-06-30$10.66M-

Basel Medical Group Ltd Ordinary Shares generated $10.05M in revenue during NA 2023, up 3.60% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Basel Medical Group Ltd Ordinary Shares Revenue by Quarter

DateRevenueChange
2025-06-30$6.05M-

Basel Medical Group Ltd Ordinary Shares generated $6.05M in revenue during Q4 2024, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Basel Medical Group Ltd Ordinary Shares Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PIIIP3 Health Partners$1.46B$386.39M
PRPOPrecipio$24.05M$6.30M
BMGLBasel Medical Group Ltd Ordinary Shares$10.05M$6.05M
NTRBNutriband$2.04M$433.40K
IBIOiBio$400.00K-
TLPHTalphera$28.00K-
MODDModular Medical--
INTSIntensity Therapeutics--
RBOTVicarious Surgical--

BMGL Revenue FAQ

What is Basel Medical Group Ltd Ordinary Shares’s yearly revenue?

Basel Medical Group Ltd Ordinary Shares's yearly revenue for 2023 was $10.05M, representing an increase of 3.60% compared to 2022. The company's yearly revenue for 2022 was $9.7M, representing a decrease of -8.98% compared to 2021. BMGL's yearly revenue for 2021 was $10.66M, representing an increase of 0% compared to 2020.

What is Basel Medical Group Ltd Ordinary Shares’s quarterly revenue?

Basel Medical Group Ltd Ordinary Shares's quarterly revenue for Q4 2024 was $6.05M, a 0% increase from the previous quarter.

What is Basel Medical Group Ltd Ordinary Shares’s revenue growth rate?

Basel Medical Group Ltd Ordinary Shares's revenue growth rate for the last 3 years (2021-2023) was -5.70%